{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:58:46Z","timestamp":1757617126380,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["22K08965"],"award-info":[{"award-number":["22K08965"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11748-024-02102-1","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:24:40Z","timestamp":1731572680000},"page":"585-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determining optimal pretreatment in cardiac surgery: an experimental study"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4678-8502","authenticated-orcid":false,"given":"Masahiro","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Bessho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"2102_CR1","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.athoracsur.2013.05.052","volume":"96","author":"Y Kotani","year":"2013","unstructured":"Kotani Y, Tweddell J, Gruber P, Pizarro C, Austin EH, Woods RK, et al. Current cardioplegia practice in pediatric cardiac surgery: a North American multiinstitutional survey. Ann Thorac Surg. 2013;96:923\u20139.","journal-title":"Ann Thorac Surg"},{"key":"2102_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0022-5223(19)33847-4","volume":"105","author":"FW Sellke","year":"1993","unstructured":"Sellke FW, Shafique T, Schoen FJ, Weintraub RM. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg. 1993;105:52\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2102_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.coph.2008.11.012","volume":"9","author":"HB Fallouh","year":"2009","unstructured":"Fallouh HB, Kentish JC, Chambers DJ. Targeting for cardioplegia: arresting agents and their safety. Curr Opin Pharmacol. 2009;9:220\u20136.","journal-title":"Curr Opin Pharmacol"},{"key":"2102_CR4","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0003-4975(99)01020-6","volume":"68","author":"DJ Chambers","year":"1999","unstructured":"Chambers DJ, Hearse DJ. Developments in cardioprotection: \u201cpolarized\u201d arrest as an alternative to \u201cdepolarized\u201d arrest. Ann Thorac Surg. 1999;68:1960\u20136.","journal-title":"Ann Thorac Surg"},{"key":"2102_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","volume":"42","author":"J Bauersachs","year":"2021","unstructured":"Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J. 2021;42:681\u20133.","journal-title":"Eur Heart J"},{"key":"2102_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5761\/atcs.oa.19-00240","volume":"26","author":"M Fujii","year":"2020","unstructured":"Fujii M, Bessho R. Neutrophil elastase inhibitor sivelestat attenuates myocardial injury after cardioplegic arrest in rat hearts. Ann Thorac Cardiovasc Surg. 2020;26:263\u20139.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2102_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008268","volume":"7","author":"RK Trivedi","year":"2018","unstructured":"Trivedi RK, Polhemus DJ, Li Z, Yoo D, Koiwaya H, Scarborough A, et al. Combined angiotensin receptor-neprilysin inhibitors improve cardiac and vascular function via increased NO bioavailability in heart failure. J Am Heart Assoc. 2018;7: e008268.","journal-title":"J Am Heart Assoc"},{"key":"2102_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/01.HYP.0000205831.39339.a5","volume":"47","author":"W Chai","year":"2006","unstructured":"Chai W, Garrelds IM, de Vries R, Danser AHJ. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone? Hypertension. 2006;47:665\u201370.","journal-title":"Hypertension"},{"key":"2102_CR9","doi-asserted-by":"publisher","first-page":"ezad405","DOI":"10.1093\/ejcts\/ezad405","volume":"64","author":"H Yamashita","year":"2023","unstructured":"Yamashita H, Fujii M, Bessho R, Ishii Y. Effect of esaxerenone on ischaemia and reperfusion injury in rat hearts. Eur J Cardiothorac Surg. 2023;64:ezad405.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2102_CR10","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1248\/bpb.b22-00616","volume":"45","author":"T Matsumoto","year":"2022","unstructured":"Matsumoto T, Kudo M, Taguchi K, Kobayashi T. Effect of nonsteroidal mineralocorticoid receptor blocker esaxerenone on vasoreactivity to an endothelial stimulator in superior mesenteric arteries of type 2 diabetic Goto-Kakizaki rat. Biol Pharm Bull. 2022;45:1825\u201331.","journal-title":"Biol Pharm Bull"},{"key":"2102_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejphar.2015.11.028","volume":"769","author":"K Arai","year":"2015","unstructured":"Arai K, Tsuruoka H, Homma T. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats. Eur J Phamacol. 2015;769:266\u201373.","journal-title":"Eur J Phamacol"},{"key":"2102_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1210\/en.2004-1130","volume":"146","author":"L Michea","year":"2005","unstructured":"Michea L, Delpiano AM, Hitschfeld C, Lobos L, Lavandero S, Marusic ET. Eplerenone blocks nongenomic effects of aldosterone on the Na+\/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology. 2005;146:973\u201380.","journal-title":"Endocrinology"},{"key":"2102_CR13","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1161\/01.CIR.102.25.3032","volume":"102","author":"P Th\u00e9roux","year":"2000","unstructured":"Th\u00e9roux P, Chaitman BR, Danchin N, Erhardt L, Meinertz Schroeder TJS, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the Guardian trial. Guard during ischemia against necrosis (Guardian) Investigators. Circulation. 2000;102:3032\u20138.","journal-title":"Circulation"},{"key":"2102_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004.","journal-title":"N Engl J Med"},{"key":"2102_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3892\/etm.2022.11431","volume":"24","author":"W Peng","year":"2022","unstructured":"Peng W, Li X, Lin Y. Application and evaluation of sacubitril\/valsartan in patients with cardiac insufficiency during perioperative period of cardiac surgery. Exp Ther Med. 2022;24:504.","journal-title":"Exp Ther Med"},{"key":"2102_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1055\/s-0042-1742685","volume":"70","author":"P Narayan","year":"2022","unstructured":"Narayan P, Kumar S, Kapoor L. Sacubitril-Valsartan in patients with ischemic cardiomyopathy undergoing off-pump coronary artery bypass grafting\u2014is it safe? Thorac Cardiovasc Surg. 2022;70:575\u20138.","journal-title":"Thorac Cardiovasc Surg"},{"key":"2102_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0022-5223(94)70010-9","volume":"108","author":"C Saldanha","year":"1994","unstructured":"Saldanha C, Hearse DJ. Cardioplegia and vascular injury. Dissociation of the effects of ischemia from those of the cardioplegic solution. J Thorac Cardiovasc Surg. 1994;108:279\u201390.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2102_CR18","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1161\/01.CIR.84.6.2485","volume":"84","author":"MW Keller","year":"1991","unstructured":"Keller MW, Geddes L, Spotnitz W, Kaul S, Duling BR. Microcirculatory dysfunction following perfusion with hyperkalemic, hypothermic, cardioplegic solutions and blood reperfusion. Effects of adenosine. Circulation. 1991;84:2485\u201394.","journal-title":"Circulation"},{"key":"2102_CR19","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s002689900657","volume":"23","author":"H Gohra","year":"1999","unstructured":"Gohra H, Fujimura Y, Hamano K, Noda H, Katoh T, Zempo N, et al. Nitric oxide release from coronary vasculature before, during, and following cardioplegic arrest. World J Surg. 1999;23:1249\u201353.","journal-title":"World J Surg"},{"key":"2102_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.5551\/jat.63382","volume":"30","author":"U Munkhjargal","year":"2023","unstructured":"Munkhjargal U, Fukuda D, Ganbaatar B, Suto K, Matsuura T, Ise T, et al. A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction in diabetic C57BL\/6 mice. J Atheroscler Thromb. 2023;30:326\u201334.","journal-title":"J Atheroscler Thromb"},{"key":"2102_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006617","volume":"6","author":"T Seki","year":"2017","unstructured":"Seki T, Goto K, Kansui Y, Ohtsubo T, Matsumura K, Kitazono T. Angiotensin II receptor-neprilysin inhibitor Sacubitril\/Valsartan improves endothelial dysfunction in spontaneously hypertensive rats. J Am Heart Assoc. 2017;6: e006617.","journal-title":"J Am Heart Assoc"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-024-02102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-024-02102-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-024-02102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:43:24Z","timestamp":1757119404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11748-024-02102-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2102"],"URL":"https:\/\/doi.org\/10.1007\/s11748-024-02102-1","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"type":"print","value":"1863-6705"},{"type":"electronic","value":"1863-6713"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}